Price at ₹1,162.70 is 20% below 200 SMA (₹1,457.99), deeply oversold.
Q4 EPS $0.23 beat $0.21 estimate, but FY26 growth only 3.1%.
Q4 EPS beat at $0.23 vs $0.21 consensus, but revenue guidance of 1.5-3.5% disappointed.
Revenue grew 4.57% YoY to ₹20,158 Cr; net income up 4.91% to ₹3,313 Cr.
Price down 33% from Feb high, 20% below 200-day SMA.
Symmetric risk/reward: ~7% upside to 50-DMA vs ~7% downside.
50-DMA at ₹1,265 vs 200-DMA at ₹1,458 shows widening structural gap.
Symmetric risk/reward: 7% upside to 50-DMA vs 7% downside to support.